HomeCorporateJBS completes US$150 million Oman multiprotein joint venture, expanding its Middle East...

JBS completes US$150 million Oman multiprotein joint venture, expanding its Middle East poultry, beef and lamb platform

Global protein producer JBS has completed a US$150 million investment in a joint venture with Oman Food Capital, establishing a multiprotein production platform in Oman covering poultry, beef and lamb.

Announced on 19 November 2026, the transaction gives JBS an 80% stake in a newly established food holding company, with Oman Food Capital holding the remaining 20%. Oman Food Capital is the food and agribusiness investment arm of the Oman Investment Authority. The transaction is a significant step in JBS’s strategy to expand its geographic presence, diversify across protein categories and strengthen its proximity to Middle Eastern consumer markets.

Two major production assets brought together

The joint venture consolidates two Omani production assets:

  • A’Namaa Poultry: An integrated poultry facility in the Ibri region of northern Oman.

  • Al Bashayer: A beef and lamb processing facility in Thumrait in southern Oman.

JBS’s investment will be directed primarily towards completing the integrated poultry plant and the beef and lamb processing facility. The company expects the combined operation, following the planned investments, to reach approximately 300,000 tonnes of annual production capacity. The projected daily processing capacity is approximately:

Protein Expected daily processing capacity
Cattle 1,000 head
Lambs 5,000 head
Chickens 600,000 birds

The operation is also expected to generate more than 3,000 direct jobs in Oman over the next five years. These are projected capacities and employment outcomes following completion of the planned investment, not necessarily current operating volumes.

Why Oman is strategically important

Oman’s location provides access to regional consumer markets across the Gulf and wider Middle East. The country’s Vision 2040 development strategy also places importance on food security, industrial development and diversification.

The joint venture is intended to strengthen local food production while positioning Oman as a production and export platform for halal protein products. For JBS, the investment provides several strategic advantages:

  1. Geographic diversification: Greater production presence in the Middle East.

  2. Protein diversification: Exposure to poultry, beef and lamb through one integrated platform.

  3. Market proximity: Production closer to important regional consumer markets.

  4. Local partnerships: Cooperation with an investment entity linked to the Omani sovereign investment system.

  5. Export potential: A platform for supplying halal products to multiple international markets.

Implications for poultry and livestock supply chains

The poultry component is particularly important because integrated poultry production requires coordination across breeding, feed, hatchery, grow-out, processing, cold-chain logistics and distribution. The proposed daily processing capacity of 600,000 chickens would represent a substantial industrial operation once fully established.

The beef and lamb components provide additional diversification. Combining several protein categories may create economies of scale in procurement, processing infrastructure, logistics and customer distribution, although the extent of those efficiencies will depend on execution.

For animal-health companies, the expansion could create opportunities across several product categories:

  • Poultry vaccines and hatchery health programmes.

  • Biosecurity and disinfection products.

  • Veterinary diagnostics.

  • Feed additives and nutritional solutions.

  • Cattle and small-ruminant vaccines.

  • Parasite-control products.

  • Animal welfare and production-monitoring technologies.

The scale of the proposed operation makes consistent disease prevention and traceability particularly important.

Biosecurity will be central to the platform’s success

Large integrated production systems can achieve strong control over health management, but they also concentrate biological and operational risk. A disease event at a breeding or hatchery facility can affect multiple downstream production units. Similarly, disruptions in feed supply, transport or processing can have consequences across the integrated system.

The platform will therefore need robust veterinary-health programmes covering vaccination, pathogen surveillance, farm-level biosecurity, transport sanitation and processing hygiene.

For poultry, priority disease-control areas include Newcastle disease, avian influenza, infectious bronchitis, infectious bursal disease and other regionally relevant pathogens. Cattle and sheep operations will require their own vaccination, parasite-control and traceability programmes based on local disease risks.

Brazil’s Newcastle disease experience provides a relevant regional lesson

The JBS transaction comes at a time when Brazil is continuing to manage the commercial and trade consequences of a Newcastle disease outbreak in Santa Catarina.

Brazil’s Ministry of Agriculture has reported that the outbreak led to temporary restrictions from several trading partners. In October, the government said it had worked with international partners to secure regionalisation of restrictions, limiting some trade measures to affected areas rather than the entire country. The Ministry estimated that regionalisation negotiations helped avoid potential losses of approximately US$954 million annually.

Malaysia subsequently recognised regionalisation and resumed imports from Brazilian regions outside Santa Catarina, while restrictions remained limited to the affected state. This illustrates how animal-health status, disease surveillance and trade negotiations can directly influence the commercial performance of major protein businesses.

What the transaction means for the global protein industry

JBS’s completed Oman investment is more than a capacity expansion. It is a strategic move towards localised production, geographic diversification and closer access to regional protein markets.

The next milestones will be the completion and commissioning of the facilities, achievement of planned processing capacity, customer-market development and the establishment of reliable animal-health and supply-chain systems. For the animal-health industry, the project is worth monitoring as a potential source of demand for poultry, cattle and small-ruminant health products and services in the Middle East.

Animal Health India Editorial Team
Animal Health India Editorial Teamhttps://animalhealthindia.com
Animal Health India (AHI) is an independent news and intelligence platform covering the global animal health, veterinary, livestock, poultry, companion animal and pet food sectors. Our editorial team comprises veterinary journalists, animal health professionals, regulatory affairs specialists and industry analysts with over 30 years of combined experience covering India, Asia, Europe and North America. AHI publishes news, regulatory updates, market intelligence and company news drawn from primary sources including DAHD, EMA, USDA, AVMA and leading veterinary publications worldwide.
RELATED ARTICLES